Reduced adiposity in ob/ob mice following total body irradiation and bone marrow transplantation

被引:34
作者
Ablamunits, Vitaly
Weisberg, Stuart P.
Lemieux, Jacob E.
Combs, Terry P.
Klebanov, Simon
机构
[1] St Lukes Hosp, Obes Res Ctr, New York, NY 10025 USA
[2] Columbia Univ, Dept Pediat, Div Mol Genet, New York, NY USA
[3] Columbia Univ, Inst Human Nutr, New York, NY USA
[4] Stanford Univ, Dept Biol Sci, Palo Alto, CA USA
[5] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA
关键词
adiposity; leptin; insulin resistance; macrophages; MONOCYTE CHEMOATTRACTANT PROTEIN-1; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; FACTOR-I; MOUSE; OBESITY; TISSUE; ADIPOCYTES; GENE; FAT;
D O I
10.1038/oby.2007.170
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objective of this study was to assess long-term metabolic consequences of total body irradiation (TBI) and bone marrow transplantation. Severe obesity develops due to both hypertrophy and hyperplasia of adipocytes. We hypothesized that TBI would arrest adipose tissue growth and would affect insulin resistance (IR). Research Methods and Procedures: We exposed 2-month-old female ob/ob mice to 8 Grays of TBI followed by bone marrow transplantation and tested the animals for body weight (BW) gain, body composition, blood glucose, and insulin sensitivity. Results: Two months after TBI, irradiated mice stopped gaining BW, whereas non-treated mice continued to grow. At the age of 9.5 months, body mass of irradiated mice was 60.6 +/- 1.4 grams, which was only 61% of that in non-treated ob/ob controls (99.4 +/- 1.6 grams). Body composition measurements by DXA showed that decreased BW was primarily due to an impaired fat accumulation. This could not result from the production of leptin by bone marrow-derived adipocyte progenitors because inhibition of the obese phenotype was identical in recipients of both B6 and ob/ob bone marrow. Inability of the irradiated mice to accumulate fat was associated with hepatomegaly, lower levels of monocyte chemoattractant protein-1 expression in adipose tissue, and increased IR. Discussion: Our data argue in favor of the hypothesis that inability of adipose tissue to expand may increase IR. This mouse model may be valuable for studies of late-onset radiation-induced IR in humans.
引用
收藏
页码:1419 / 1429
页数:11
相关论文
共 39 条
[1]   Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation [J].
Adams, M ;
Montague, CT ;
Prins, JB ;
Holder, JC ;
Smith, SA ;
Sanders, L ;
Digby, JE ;
Sewter, CP ;
Lazar, MA ;
Chatterjee, VKK ;
O'Rahilly, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :3149-3153
[2]   Efficacy of troglitazone on body fat distribution in type 2 diabetes [J].
Akazawa, S ;
Sun, FY ;
Ito, M ;
Kawasaki, E ;
Eguchi, K .
DIABETES CARE, 2000, 23 (08) :1067-1071
[3]   A high-resolution map around the locus Om on mouse Chromosome 11 [J].
Baldacci, PA ;
CohenTannoudji, M ;
Kress, C ;
Pournin, S ;
Babinet, C .
MAMMALIAN GENOME, 1996, 7 (02) :114-116
[4]   INSULIN RESISTANCE OF INHERENTLY OBESE MOUSE - OBOB [J].
BATT, R ;
MIALHE, P .
NATURE, 1966, 212 (5059) :289-&
[5]   GROWTH AND MATURATION OF PRIMARY-CULTURED ADIPOCYTES FROM LEAN AND OB/OB MICE [J].
BLACK, MA ;
BEGINHEICK, N .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 58 (04) :455-463
[6]   HYPOTHALAMIC AND GENETIC OBESITY IN EXPERIMENTAL-ANIMALS - AUTONOMIC AND ENDOCRINE HYPOTHESIS [J].
BRAY, GA ;
YORK, DA .
PHYSIOLOGICAL REVIEWS, 1979, 59 (03) :719-809
[7]  
CECCHINI MG, 1994, DEVELOPMENT, V120, P1357
[8]   OBESITY AND INSULIN RESISTANCE IN OBESE-HYPERGLYCEMIC MOUSE (OBOB) [J].
CHLOUVERAKIS, C ;
WHITE, PA .
METABOLISM, 1969, 18 (12) :998-+
[9]   Failure of adipocyte differentiation causes type II diabetes mellitus? [J].
Danforth, E .
NATURE GENETICS, 2000, 26 (01) :13-13
[10]   Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes [J].
Fasshauer, M ;
Klein, J ;
Kralisch, S ;
Klier, M ;
Lossner, U ;
Bluher, M ;
Paschke, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (02) :598-604